DLGAP5 and neoplasm: Furthermore, in a mouse subcutaneous xenograft model, tumors formed from DLGAP5-silenced cells exhibited greater sensitivity to GEM, as evidenced by reduced tumor size, weight, growth rate, and lower Ki-67 levels compared to control groups.